share_log

Evercore ISI Group Upgrades Health Catalyst to Outperform, Raises Price Target to $11

Benzinga ·  Jan 3 08:06

Evercore ISI Group analyst Elizabeth Anderson upgrades Health Catalyst (NASDAQ:HCAT) from In-Line to Outperform and raises the price target from $9 to $11.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment